330 related articles for article (PubMed ID: 16729722)
1. Interferon alpha and its contribution to autoimmunity.
Selmi C; Lleo A; Zuin M; Podda M; Rossaro L; Gershwin ME
Curr Opin Investig Drugs; 2006 May; 7(5):451-6. PubMed ID: 16729722
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
[TBL] [Abstract][Full Text] [Related]
3. Systemic lupus erythematosus and Sjögren's syndrome induced in a case by interferon-alpha used for the treatment of hepatitis C.
Onishi S; Nagashima T; Kimura H; Matsuyama Y; Yoshio T; Minota S
Lupus; 2010 May; 19(6):753-5. PubMed ID: 20064909
[TBL] [Abstract][Full Text] [Related]
4. Syndromes and complications of interferon therapy.
Borg FA; Isenberg DA
Curr Opin Rheumatol; 2007 Jan; 19(1):61-6. PubMed ID: 17143098
[TBL] [Abstract][Full Text] [Related]
5. Interferon alpha and neuromuscular disorders.
Stübgen JP
J Neuroimmunol; 2009 Feb; 207(1-2):3-17. PubMed ID: 19171385
[TBL] [Abstract][Full Text] [Related]
6. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.
Lövgren T; Eloranta ML; Kastner B; Wahren-Herlenius M; Alm GV; Rönnblom L
Arthritis Rheum; 2006 Jun; 54(6):1917-27. PubMed ID: 16729300
[TBL] [Abstract][Full Text] [Related]
7. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.
Mandac JC; Chaudhry S; Sherman KE; Tomer Y
Hepatology; 2006 Apr; 43(4):661-72. PubMed ID: 16557537
[TBL] [Abstract][Full Text] [Related]
8. Retroviruses in autoimmune liver disease: genetic or environmental agents?
Mason AL; Xu L; Guo L; Garry RF
Arch Immunol Ther Exp (Warsz); 1999; 47(5):289-97. PubMed ID: 10604234
[TBL] [Abstract][Full Text] [Related]
9. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.
Båve U; Nordmark G; Lövgren T; Rönnelid J; Cajander S; Eloranta ML; Alm GV; Rönnblom L
Arthritis Rheum; 2005 Apr; 52(4):1185-95. PubMed ID: 15818675
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
[TBL] [Abstract][Full Text] [Related]
11. [Interferon therapy in chronic viral hepatitis; an autoimmunity dilemma].
Gutkowski K; Gutkowska D; Bilkiewicz T
Przegl Lek; 2007; 64(3):148-52. PubMed ID: 17941466
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis C and immunologic anomalies].
Lunel F
Gastroenterol Clin Biol; 1994; 18(10):829-38. PubMed ID: 7875390
[No Abstract] [Full Text] [Related]
13. Immunity, autoimmunity and autoimmune diseases in older people.
Rosato E; Salsano F
J Biol Regul Homeost Agents; 2008; 22(4):217-24. PubMed ID: 19036223
[TBL] [Abstract][Full Text] [Related]
14. Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity.
Devendra D; Eisenbarth GS
Clin Immunol; 2004 Jun; 111(3):225-33. PubMed ID: 15183143
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus and type 1 diabetes.
Fallahi P; Di Domenicantonio A; Mazzi V; Santini F; Fabiani S; Sebastiani M; Zignego AL; Ferri C; Antonelli A
Clin Ter; 2013; 164(5):e437-44. PubMed ID: 24217846
[TBL] [Abstract][Full Text] [Related]
16. [Interferon alpha (IFNalpha) treatment for Sjögren's syndrome].
Shiozawa K; Shiozawa S
Nihon Rinsho; 2006 Jul; 64(7):1345-53. PubMed ID: 16838655
[TBL] [Abstract][Full Text] [Related]
17. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
Lood C; Gullstrand B; Truedsson L; Olin AI; Alm GV; Rönnblom L; Sturfelt G; Eloranta ML; Bengtsson AA
Arthritis Rheum; 2009 Oct; 60(10):3081-90. PubMed ID: 19790049
[TBL] [Abstract][Full Text] [Related]
18. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
Guzman Moreno R
Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
[TBL] [Abstract][Full Text] [Related]
19. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
[TBL] [Abstract][Full Text] [Related]
20. [Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis].
Ettinger OA; Nikitin IG; Storozhakov GI
Ter Arkh; 1999; 71(12):69-72. PubMed ID: 10647210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
